"Pharmaceutical Research Trials"

During the past decade, Multi-Specialty Research Associates, Inc. conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 11 clinical trials were completed, i.e. on average, 44% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 11 clinical trials were completed. i.e. 73.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Multi-Specialty Research Associates, Inc." #1 sponsor was "Pfizer" with 10 trials, followed by "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Forte Biosciences, Inc." with 2 trials sponsored and "Satsuma Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Multi-Specialty Research Associates, Inc." #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Multi-Specialty Research Associates, Inc." are "Migraine" (6 trials), "Migraine, With or Without Aura" (3 trials), "Atopic Dermatitis" (2 trials), "Hot Flashes" (2 trials) and "Migraine With Aura" (2 trials). Many other conditions were trialed in "Multi-Specialty Research Associates, Inc." in a lesser frequency.

Most popular intervention types in "Multi-Specialty Research Associates, Inc." are "Drug" (20 trials), "Biological" (4 trials), "Device" (2 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Rimegepant" (4 trials), "Dihydroergotamine" (2 trials), "FB-401" (2 trials) and "Zavegepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Multi-Specialty Research Associates, Inc." are 24 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Multi-Specialty Research Associates, Inc.". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Multi-Specialty Research Associates, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Multi-Specialty Research Associates, Inc., 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".